|
2023-10-31 |
2023-10-18 |
B
Purchase
|
Large shareholder
|
26,961
433.33
US$4,208,101
|
26,961
|
433.33
|
US$4,208,101
|
|
|
2023-10-31 |
2023-10-18 |
B
Purchase
|
Large shareholder
|
79,874
328.52
US$3,768,805
|
79,874
|
328.52
|
US$3,768,805
|
|
|
2021-02-26 |
2021-02-24 |
PlS
Planned sale
|
Chief Medical Officer
Officer
|
1,855
+42.9%
129.29
US$4,207,799
|
1,855
+42.9%
|
129.29
|
US$4,207,799
|
|
|
2021-02-24 |
2021-02-24 |
PlS
Planned sale
|
President & CEO
Executive Director
|
10,800
-6.9%
17.40
US$187,919
|
10,800
-6.9%
|
17.40
|
US$187,919
|
|
|
2021-02-24 |
2021-02-23 |
PlS
Planned sale
|
President & CEO
Executive Director
|
7,126
-4.4%
17.89
US$127,483
|
7,126
-4.4%
|
17.89
|
US$127,483
|
|
|
2021-02-24 |
2021-02-22 |
PlS
Planned sale
|
President & CEO
Executive Director
|
15,200
-8.5%
19.86
US$301,813
|
15,200
-8.5%
|
19.86
|
US$301,813
|
|
|
2021-01-22 |
2021-01-21 |
PlS
Planned sale
|
President & CEO
Executive Director
|
1,406
-0.8%
15.04
US$21,147
|
1,406
-0.8%
|
15.04
|
US$21,147
|
|
|
2021-01-22 |
2021-01-20 |
PlS
Planned sale
|
Chief Medical Officer
Officer
|
3,000
-26.0%
15.03
US$45,084
|
3,000
-26.0%
|
15.03
|
US$45,084
|
|
|
2021-01-22 |
2021-01-20 |
PlS
Planned sale
|
President & CEO
Executive Director
|
19,466
-9.8%
15.03
US$292,533
|
19,466
-9.8%
|
15.03
|
US$292,533
|
|
|
2021-03-08 |
2020-12-23 |
B
Purchase
|
Non-Executive Director
|
4
+1.6%
11.56
US$46
|
4
+1.6%
|
11.56
|
US$46
|
|
|
2021-03-08 |
2020-09-14 |
B
Purchase
|
Non-Executive Director
|
1
+0.4%
10.70
US$11
|
1
+0.4%
|
10.70
|
US$11
|
|
|
2021-03-08 |
2020-09-11 |
B
Purchase
|
Non-Executive Director
|
10
+4.3%
10.07
US$101
|
10
+4.3%
|
10.07
|
US$101
|
|
|
2021-03-08 |
2020-08-14 |
B
Purchase
|
Non-Executive Director
|
5
+2.2%
11.07
US$55
|
5
+2.2%
|
11.07
|
US$55
|
|
|
2021-03-08 |
2020-07-17 |
B
Purchase
|
Non-Executive Director
|
4
+1.8%
11.86
US$47
|
4
+1.8%
|
11.86
|
US$47
|
|
|
2021-03-08 |
2020-07-07 |
B
Purchase
|
Non-Executive Director
|
1
+0.4%
9.60
US$10
|
1
+0.4%
|
9.60
|
US$10
|
|
|
2021-03-08 |
2020-05-12 |
B
Purchase
|
Non-Executive Director
|
25
+12.5%
15.02
US$376
|
25
+12.5%
|
15.02
|
US$376
|
|
|
2020-05-14 |
2020-05-12 |
B
Purchase
|
Large shareholder
|
500,000
+30.1%
15.00
US$7,500,000
|
500,000
+30.1%
|
15.00
|
US$7,500,000
|
|
|
2020-05-14 |
2020-05-12 |
B
Purchase
|
Large shareholder
|
50,000
+3.1%
15.00
US$750,000
|
50,000
+3.1%
|
15.00
|
US$750,000
|
|
|
2020-05-14 |
2020-05-12 |
B
Purchase
|
Large shareholder
|
225,000
+7.3%
15.00
US$3,375,000
|
225,000
+7.3%
|
15.00
|
US$3,375,000
|
|
|
2020-05-14 |
2020-05-12 |
B
Purchase
|
Large shareholder
|
800,000
+36.5%
15.00
US$12,000,000
|
800,000
+36.5%
|
15.00
|
US$12,000,000
|
|
|
2021-03-08 |
2020-05-08 |
B
Purchase
|
Non-Executive Director
|
200
+inf%
15.27
US$3,054
|
200
+inf%
|
15.27
|
US$3,054
|
|
|
2020-03-16 |
2020-03-13 |
S
Sale
|
Non-Executive Director
|
2,401
-18.6%
0.55
US$1,321
|
2,401
-18.6%
|
0.55
|
US$1,321
|
|
|
2020-03-16 |
2020-03-12 |
S
Sale
|
Non-Executive Director
|
200
-1.5%
0.58
US$116
|
200
-1.5%
|
0.58
|
US$116
|
|
|
2020-03-16 |
2020-03-11 |
S
Sale
|
Non-Executive Director
|
399
-3.0%
0.67
US$267
|
399
-3.0%
|
0.67
|
US$267
|
|
|
2019-04-11 |
2019-04-10 |
B
Purchase
|
|
3,000
+28.6%
3.80
US$11,391
|
3,000
+28.6%
|
3.80
|
US$11,391
|
|
|
2018-11-07 |
2018-11-05 |
S
Sale
|
PETIT ROBERT
Chief Scientific Officer
Officer
|
3,963
-1.7%
0.58
US$2,299
|
3,963
-1.7%
|
0.58
|
US$2,299
|
|
|
2018-11-05 |
2018-11-02 |
S
Sale
|
PETIT ROBERT
Chief Scientific Officer
Officer
|
8,491
-3.5%
0.56
US$4,755
|
8,491
-3.5%
|
0.56
|
US$4,755
|
|
|
2018-09-13 |
2018-09-11 |
B
Purchase
|
Non-Executive Director
|
33,333
+26.9%
1.20
US$40,000
|
33,333
+26.9%
|
1.20
|
US$40,000
|
|
|
2018-04-03 |
2018-04-02 |
S
Sale
|
PETIT ROBERT
Chief Scientific Officer
|
2,193
-1.0%
1.62
US$3,553
|
2,193
-1.0%
|
1.62
|
US$3,553
|
|
|
2018-02-02 |
2018-02-02 |
S
Sale
|
Interim CEO
Officer
|
32
-0.0%
2.93
US$94
|
32
-0.0%
|
2.93
|
US$94
|
|
|
2018-01-03 |
2018-01-03 |
S
Sale
|
Bonstein Sara
Chief Financial Officer
Officer
|
5,224
-2.3%
3.18
US$16,612
|
5,224
-2.3%
|
3.18
|
US$16,612
|
|
|
2017-11-06 |
2017-11-06 |
S
Sale
|
Bonstein Sara
Chief Financial Officer
|
3,862
-1.7%
3.30
US$12,745
|
3,862
-1.7%
|
3.30
|
US$12,745
|
|
|
2017-11-06 |
2017-11-06 |
S
Sale
|
Chief Scientific Officer
|
3,723
-1.7%
3.30
US$12,286
|
3,723
-1.7%
|
3.30
|
US$12,286
|
|
|
2017-11-02 |
2017-11-02 |
S
Sale
|
LOMBARDO ANTHONY A
Interim CEO
|
24
-0.0%
3.19
US$77
|
24
-0.0%
|
3.19
|
US$77
|
|
|
2017-11-02 |
2017-11-02 |
S
Sale
|
Chief Scientific Officer
|
12,625
-5.3%
3.19
US$40,274
|
12,625
-5.3%
|
3.19
|
US$40,274
|
|
|
2017-11-02 |
2017-11-02 |
S
Sale
|
Chief Financial Officer
|
12,734
-5.2%
3.19
US$40,621
|
12,734
-5.2%
|
3.19
|
US$40,621
|
|
|
2017-10-12 |
2017-10-11 |
S
Sale
|
ADAGE CAPITAL PARTNERS GP, L.L.C.
Large shareholder
|
600,000
-12.8%
4.30
US$2,580,000
|
600,000
-12.8%
|
4.30
|
US$2,580,000
|
|
|
2017-09-26 |
2017-09-26 |
S
Sale
|
ADAGE CAPITAL PARTNERS GP, L.L.C.
Large shareholder
|
300,000
-6.0%
4.00
US$1,200,000
|
300,000
-6.0%
|
4.00
|
US$1,200,000
|
|
|
2017-09-26 |
2017-09-25 |
S
Sale
|
ADAGE CAPITAL PARTNERS GP, L.L.C.
Large shareholder
|
405,323
-7.5%
4.38
US$1,775,315
|
405,323
-7.5%
|
4.38
|
US$1,775,315
|
|
|
2017-09-26 |
2017-09-22 |
S
Sale
|
ADAGE CAPITAL PARTNERS GP, L.L.C.
Large shareholder
|
534,000
-9.0%
4.68
US$2,499,120
|
534,000
-9.0%
|
4.68
|
US$2,499,120
|
|
|
2017-04-03 |
2017-03-31 |
S
Sale
|
PETIT ROBERT
Chief Scientific Officer
|
2,454
-2.0%
8.24
US$20,221
|
2,454
-2.0%
|
8.24
|
US$20,221
|
|
|
2017-01-03 |
2016-12-30 |
S
Sale
|
Bonstein Sara
Chief Financial Officer
Officer
|
5,520
-4.2%
7.37
US$40,682
|
5,520
-4.2%
|
7.37
|
US$40,682
|
|
|
2016-12-21 |
2016-12-20 |
S
Sale
|
MCKEARN THOMAS J
Non-Executive Director
|
12,316
-15.0%
8.08
US$99,513
|
12,316
-15.0%
|
8.08
|
US$99,513
|
|
|
2016-11-02 |
2016-11-02 |
S
Sale
|
PETIT ROBERT
Chief Scientific Officer
Officer
|
2,797
-2.3%
8.32
US$23,271
|
2,797
-2.3%
|
8.32
|
US$23,271
|
|
|
2016-11-02 |
2016-11-02 |
S
Sale
|
O'Connor Daniel
Chief Executive Officer
Executive Director
|
8,240
-2.7%
8.32
US$68,557
|
8,240
-2.7%
|
8.32
|
US$68,557
|
|
|
2016-10-26 |
2016-10-25 |
S
Sale
|
Mayes, Gregory T.
Chief Business Officer
Executive Director
|
19,162
-15.7%
8.23
US$157,703
|
19,162
-15.7%
|
8.23
|
US$157,703
|
|
|
2016-08-10 |
2016-08-09 |
S
Sale
|
Non-Executive Director
|
15,761
-23.7%
15.67
US$246,975
|
15,761
-23.7%
|
15.67
|
US$246,975
|
|
|
2016-08-10 |
2016-08-09 |
S
Sale
|
Non-Executive Director
|
11,404
-12.4%
14.85
US$169,349
|
11,404
-12.4%
|
14.85
|
US$169,349
|
|
|
2016-08-10 |
2016-08-08 |
S
Sale
|
Non-Executive Director
|
18,000
-21.3%
15.21
US$273,780
|
18,000
-21.3%
|
15.21
|
US$273,780
|
|
|
2016-08-10 |
2016-08-08 |
S
Sale
|
Non-Executive Director
|
11,404
-11.1%
15.17
US$172,999
|
11,404
-11.1%
|
15.17
|
US$172,999
|
|
|
2016-05-13 |
2016-05-13 |
S
Sale
|
MCKEARN THOMAS J
Non-Executive Director
|
4,100
-4.8%
7.45
US$30,545
|
4,100
-4.8%
|
7.45
|
US$30,545
|
|
|
2016-05-02 |
2016-05-02 |
S
Sale
|
PETIT ROBERT
Chief Scientific Officer
Officer
|
2,785
-2.2%
7.51
US$20,915
|
2,785
-2.2%
|
7.51
|
US$20,915
|
|
|
2016-05-02 |
2016-05-02 |
S
Sale
|
O'Connor Daniel
Chief Executive Officer
Officer
|
8,237
-2.6%
7.51
US$61,860
|
8,237
-2.6%
|
7.51
|
US$61,860
|
|
|
2016-04-01 |
2016-03-31 |
S
Sale
|
Chief Scientific Officer
Officer
|
3,325
-2.5%
9.13
US$30,357
|
3,325
-2.5%
|
9.13
|
US$30,357
|
|
|
2016-03-18 |
2016-03-16 |
S
Sale
|
Non-Executive Director
|
14,000
-14.0%
8.25
US$115,500
|
14,000
-14.0%
|
8.25
|
US$115,500
|
|
|
2016-02-25 |
2016-02-24 |
S
Sale
|
Chief Financial Officer
Officer
|
15,037
-15.8%
5.58
US$83,906
|
15,037
-15.8%
|
5.58
|
US$83,906
|
|
|
2016-02-01 |
2016-01-29 |
S
Sale
|
Chief Scientific Officer
Officer
|
3,099
-2.3%
6.88
US$21,321
|
3,099
-2.3%
|
6.88
|
US$21,321
|
|
|
2016-02-01 |
2016-01-29 |
S
Sale
|
O'Connor Daniel
Chief Executive Officer
Officer
|
8,818
-2.7%
6.88
US$60,668
|
8,818
-2.7%
|
6.88
|
US$60,668
|
|
|
2015-08-24 |
2015-08-24 |
B
Purchase
|
ADAGE CAPITAL PARTNERS GP LLC
Large shareholder
|
12,100
+0.2%
14.47
US$175,087
|
12,100
+0.2%
|
14.47
|
US$175,087
|
|
|
2015-08-24 |
2015-08-24 |
B
Purchase
|
ADAGE CAPITAL PARTNERS GP LLC
Large shareholder
|
9,500
+0.2%
13.73
US$130,435
|
9,500
+0.2%
|
13.73
|
US$130,435
|
|
|
2015-08-24 |
2015-08-24 |
B
Purchase
|
ADAGE CAPITAL PARTNERS GP LLC
Large shareholder
|
3,400
+0.1%
14.06
US$47,804
|
3,400
+0.1%
|
14.06
|
US$47,804
|
|
|
2015-08-24 |
2015-08-24 |
B
Purchase
|
ADAGE CAPITAL PARTNERS GP LLC
Large shareholder
|
20,000
+0.3%
12.90
US$258,000
|
20,000
+0.3%
|
12.90
|
US$258,000
|
|
|
2015-08-24 |
2015-08-24 |
B
Purchase
|
ADAGE CAPITAL PARTNERS GP LLC
Large shareholder
|
5,000
+0.1%
13.87
US$69,350
|
5,000
+0.1%
|
13.87
|
US$69,350
|
|
|
2015-08-24 |
2015-08-21 |
B
Purchase
|
ADAGE CAPITAL PARTNERS GP LLC
Large shareholder
|
75,000
+1.3%
14.21
US$1,065,750
|
75,000
+1.3%
|
14.21
|
US$1,065,750
|
|
|
2015-08-24 |
2015-08-20 |
B
Purchase
|
ADAGE CAPITAL PARTNERS GP LLC
Large shareholder
|
12,000
+0.2%
14.17
US$170,040
|
12,000
+0.2%
|
14.17
|
US$170,040
|
|
|
2015-08-24 |
2015-08-20 |
B
Purchase
|
ADAGE CAPITAL PARTNERS GP LLC
Large shareholder
|
13,600
+0.2%
14.31
US$194,616
|
13,600
+0.2%
|
14.31
|
US$194,616
|
|
|
2015-08-24 |
2015-08-20 |
B
Purchase
|
ADAGE CAPITAL PARTNERS GP LLC
Large shareholder
|
45,582
+0.8%
14.32
US$652,734
|
45,582
+0.8%
|
14.32
|
US$652,734
|
|
|
2015-08-24 |
2015-08-20 |
B
Purchase
|
ADAGE CAPITAL PARTNERS GP LLC
Large shareholder
|
103,818
+1.8%
14.28
US$1,482,521
|
103,818
+1.8%
|
14.28
|
US$1,482,521
|
|
|
2015-05-04 |
2015-04-30 |
B
Purchase
|
ADAGE CAPITAL PARTNERS GP LLC
Large shareholder
|
500,000
+9.7%
19.00
US$9,500,000
|
500,000
+9.7%
|
19.00
|
US$9,500,000
|
|
|
2015-02-20 |
2015-02-18 |
B
Purchase
|
ADAGE CAPITAL PARTNERS GP LLC
Large shareholder
|
684,762
+15.4%
7.50
US$5,135,715
|
684,762
+15.4%
|
7.50
|
US$5,135,715
|
|
|
2014-05-09 |
2014-05-09 |
S
Sale
|
Non-Executive Director
|
7,530
-100.0%
2.63
US$19,823
|
7,530
-100.0%
|
2.63
|
US$19,823
|
|
|
2014-05-09 |
2014-05-09 |
S
Sale
|
Non-Executive Director
|
7,000
-48.2%
2.63
US$18,425
|
7,000
-48.2%
|
2.63
|
US$18,425
|
|
|
2014-04-02 |
2014-03-31 |
B
Purchase
|
O'Connor Daniel
Chief Executive Officer
Executive Director
|
3,333
+1.1%
3.00
US$9,999
|
3,333
+1.1%
|
3.00
|
US$9,999
|
|
|
2013-10-29 |
2013-10-24 |
B
Purchase
|
Non-Executive Director
|
25,000
+39.7%
4.00
US$100,000
|
25,000
+39.7%
|
4.00
|
US$100,000
|
|
|
2013-10-29 |
2013-10-24 |
B
Purchase
|
Non-Executive Director
|
12,500
+28.1%
4.00
US$50,000
|
12,500
+28.1%
|
4.00
|
US$50,000
|
|